Project Description

Dissecting the CMS Best Price Rule:
What it Means for Manufacturer Co-Pay Programs

TrialCard TALK Podcast
Jason Zemcik, Senior Director of Product Management, TrialCard


In December 2020 the Centers for Medicare and Medicaid Services (CMS) finalized a rule around best price impact for manufacturer co-pay assistance programs affected by accumulator adjustments.

In this podcast, Jason Zemcik, Sr. Director of Product Management at TrialCard, breaks down the implications of this rule, outlines strategies for manufacturers to address it, and provides insight on other drug pricing policy matters that could affect how manufacturers deliver patient support programs going forward.

Please submit the form below to view this resource.

Request Resource